By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


arGEN-X N.V. 

Willemstraat 5

Breda    4811 AH  The Nederlands
Phone: 31-0-10-763-030-488 Fax: n/a



Start Up

Company News
AbbVie (ABBV) Gets First Dibs on arGEN-X's Immuno-Oncology Drug in Deal Worth $685 Million 4/21/2016 5:59:10 AM
arGEN-X Reports Fourth Quarter Business Update And Full Year 2015 Financial Results 3/11/2016 9:00:53 AM
arGEN-X Opens Clinical Trial Sites In South Korea For ARGX-111 Program 2/18/2016 8:42:01 AM
arGEN-X To Present At The LEERINK Partners 5th Annual Global Healthcare Conference 2/5/2016 8:52:59 AM
arGEN-X Receives Milestone Payment In LEO Pharma Collaboration 2/2/2016 9:10:02 AM
arGEN-X, LEO Pharma Forge $116 Million Skin Pact 5/22/2015 5:37:49 AM
Forbion Announces Closing Of Initial Public Offering Of Portfolio Company arGEN-X 7/9/2014 9:09:43 AM
Dutch Biotech arGEN-X Plans To Go Public In Brussels 6/10/2014 7:26:33 AM
arGEN-X Inks Long-Term Alliance With Shire Pharmaceuticals (SHPG) Worth $20.4 Million 6/4/2014 6:31:23 AM
arGEN-X Uses Its Simple Antibody™ Platform To Identify Four "Hotspots" On MET As Targets For Its Therapeutic Antibody Program 4/7/2014 9:23:05 AM